Report: Drug Companies’ R&D Initiatives Increased in 2011
In 2011, the number of new innovative drug treatments to enter the global consumer market reached a 10-year high of 31, compared with 21 new treatments in 2010, according to a recent report by Thomson Reuters unit CMR International. In addition, researchers in 2011 experienced higher success rates in the costly final stages of development, the report found.
- "Drug Pipelines Improving After Years in Doldrums" (Hirschler, Reuters, 6/26).